SophAI • Entrepreneurship Radar

Entrepreneurship today is fueled by deep tech investment and real-world utility, but capital flows remain uneven. Switzerland leads in deep tech venture allocation, while a Latin American healthtech startup secures major US funding and grassroots projects prove usefulness without hype. This radar explores where founders should focus to balance innovation, funding, and impact.

Deep Tech Bias Reshapes Entrepreneurial Funding

Switzerland now invests 63% of venture capital into deep tech, outpacing China and the US, with annual funding reaching a record $2.6B in 2025 ^[1]. This surge is driven by AI and machine learning, which now account for one in four new deep tech startups ^[1]. Meanwhile, Telepatia, a healthtech startup leveraging AI to prevent medication errors, closed a $33M Series A led by a16z—a direct example of capital chasing high-tech, founder-led ventures that address systemic gaps ^[2]. The message for entrepreneurs: deep tech and AI are where VC dollars are concentrated, making them attractive sectors for scaling.

Global Capital versus Local Ecosystem Resilience

While deep tech attracts massive funding, the Swiss report reveals a critical tension: foreign investors supply 88% of capital for rounds above $100M, with US funds alone at 54%, while domestic capital drops from 36% of small rounds to 12% of large ones ^[1]. Telepatia’s Latin American roots highlight a similar dynamic—regional shortages of clinicians (43% fewer physicians than OECD) ^[2] contrast with a US-led funding source. In parallel, HackerNoon’s Projects of the Week feature three startups—Yaeum, XColdPro, and EquipmentStack—that prove real-world utility without massive VC backing ^[3]. This underscores a balancing act: global capital enables scale, but local innovation must maintain resilience and practical value.

Strategic Imperatives

For CXOs and founders navigating this landscape, the following actions are critical:

• Double down on deep tech differentiation—leverage AI and machine learning to address concrete problems, as Telepatia does with medication errors and Swiss startups dominate with high VC allocation ^[1][2].
• Diversify funding sources early—build relationships with both domestic investors for early-stage rounds and international (especially US) capital for later scaling, while retaining long-term control ^[1].
• Prove usefulness over hype—use metrics and real-world impact, as the HackerNoon projects show, to attract customers and investors even without massive funding ^[3].